Several advancements in bioprocessing infrastructure are highlighted, including the opening of the University of Oklahoma’s state-of-the-art bioprocessing core facility designed to support upstream and downstream biologics manufacturing. This initiative aims to enhance workforce training and bioengineering research, fostering growth in biomanufacturing. Additionally, BMG LABTECH launched Enhanced Dynamic Range technology to improve enzymatic assay precision, streamlining biochemical analyses critical to drug discovery and validation.